标题
Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors
作者
关键词
-
出版物
Nature Communications
Volume 13, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-03-28
DOI
10.1038/s41467-022-29225-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
- (2022) Zhen Cui et al. CELL
- Kinetics and persistence of cellular and humoral immune responses to SARS‐CoV‐2 vaccine in healthcare workers with or without prior COVID‐19
- (2022) Mihaela Chivu‐Economescu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2
- (2021) Saman Saadat et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2021) Zhiwei Wu et al. LANCET INFECTIOUS DISEASES
- Delaying a COVID vaccine’s second dose boosts immune response
- (2021) Heidi Ledford NATURE
- Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
- (2021) Joseph E. Ebinger et al. NATURE MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
- (2021) Frauke Muecksch et al. IMMUNITY
- SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain
- (2021) Rafael Bayarri-Olmos et al. JOURNAL OF IMMUNOLOGY
- Marked Increase in Avidity of SARS-CoV-2 Antibodies 7–8 Months After Infection Is Not Diminished in Old Age
- (2021) Daniel Pichler et al. JOURNAL OF INFECTIOUS DISEASES
- Antibody‐dependent neutralizing capacity of the SARS‐CoV‐2 vaccine BNT162b2 with and without previous COVID‐19 priming
- (2021) Cecilie Bo Hansen et al. JOURNAL OF INTERNAL MEDICINE
- SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
- (2021) Jackson S. Turner et al. NATURE
- mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar
- (2021) Hiam Chemaitelly et al. NATURE MEDICINE
- Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
- (2021) Moriah Bergwerk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
- (2021) Stephen J. Thomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
- (2021) Jia Wei et al. Nature Microbiology
- The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity
- (2021) Jennifer Abbasi JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals
- (2021) Brian Grunau et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
- (2021) Alice Cho et al. NATURE
- Immunogenicity and efficacy of heterologous ChAdOx1–BNT162b2 vaccination
- (2021) Bruno Pozzetto et al. NATURE
- Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
- (2021) Koen B. Pouwels et al. NATURE MEDICINE
- Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents
- (2021) Ben Y. Reis et al. NEW ENGLAND JOURNAL OF MEDICINE
- BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant
- (2021) Aziz Sheikh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine
- (2021) Annalisa Ciabattini et al. Frontiers in Immunology
- Kinetics and persistence of anti‐SARS‐CoV‐2 neutralisation and antibodies after BNT162b2 vaccination in a Swiss cohort
- (2021) Lara Šošić et al. Immunity Inflammation and Disease
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
- (2020) Shengli Xia et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals
- (2020) Cecilie Bo Hansen et al. JOURNAL OF IMMUNOLOGY
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- IgA dominates the early neutralizing antibody response to SARS-CoV-2
- (2020) Delphine Sterlin et al. Science Translational Medicine
- Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection
- (2020) Michael W. Russell et al. Frontiers in Immunology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now